−0.151SEK
−44.05 MSEK
About ANNEXIN PHARMACEUTICALS AB
Sector
CEO
Nils Anders Haegerstrand
Headquarters
Stockholm
Website
Employees (FY)
4
Founded
2014
ISIN
SE0009664154
FIGI
BBG00GGV2H53
Annexin Pharmaceuticals AB operates as a biotechnology company. It develops treatment of various cardiovascular diseases. The firm establishes and optimizes a cell line for large-scale production of Annexin A5. The company was founded by Anna Frostegård in 2014 and is headquartered in Stockholm, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ANNX is 0.269 SEK — it has decreased by 0.74% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ANNEXIN PHARMACEUTICALS AB stocks are traded under the ticker ANNX.
ANNX stock is 3.01% volatile and has beta coefficient of 2.63. Check out the list of the most volatile stocks — is ANNEXIN PHARMACEUTICALS AB there?
Yes, you can track ANNEXIN PHARMACEUTICALS AB financials in yearly and quarterly reports right on TradingView.
ANNX stock has fallen by 2.54% compared to the previous week, the month change is a 0.37% fall, over the last year ANNEXIN PHARMACEUTICALS AB has showed a 59.08% decrease.
ANNX net income for the last quarter is −12.46 M SEK, while the quarter before that showed −14.55 M SEK of net income which accounts for 14.36% change. Track more ANNEXIN PHARMACEUTICALS AB financial stats to get the full picture.
Today ANNEXIN PHARMACEUTICALS AB has the market capitalization of 93.92 M, it has increased by 10.98% over the last week.
No, ANNX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ANNX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANNEXIN PHARMACEUTICALS AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 4.00 employees. See our rating of the largest employees — is ANNEXIN PHARMACEUTICALS AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ANNEXIN PHARMACEUTICALS AB technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ANNEXIN PHARMACEUTICALS AB stock shows the sell signal. See more of ANNEXIN PHARMACEUTICALS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.